is hers semaglutide safe Online GLP-1 Clinic Review Hims & Hers tackles high

Semaglutide and Tirzepatide Semaglutide is primarily a GLP-1 receptor agonist Tirzepatide targets GLP-1 and GIP receptors Retatrutide targets GLP-1, GIP, and glucagon receptor pathways Because retatrutide activates additional metabolic receptors, some studies suggest that retatrutide may deliver greater weight loss compared with semaglutide and tirzepatide

When to Contact a Healthcare Provider Most GLP-1 side effects are not serious

Some compounding pharmacies claim to offer it, but the FDA has not approved any compounded version of retatrutide

UK Availability At present, retatrutide is not approved for prescription or retail use in the UK

Roman's weight loss program is direct-pay only and does not accept insurance

Among patients on weekly GLP-1/GIP medications, the proportion of patients without clinically significant RGV was significantly higher in those who held the medication for more than 3 days (38 patients [92.7%]) compared with 3 days or less (5 patients [62.5%]) ( P = .047)